Clinical features of BRCA-positive ovarian cancer
It has been recently proved that cells with impaired BRCA1function demonstrate high sensitivity to platinum-containing derivatives because they are not able to eliminate DNA disorders caused by these agents. Early studies showed that BRCA carriers had better odds of surviving ovarian cancer than do...
Main Authors: | S. Ya. Maximov, E. N. Imyanitov, K. D. Guseinov, T. V. Gorodnova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-02-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/248 |
Similar Items
-
ОСОБЕННОСТИ ЭКСПРЕССИИ РЕЦЕПТОРОВ ЭСТРОГЕНОВ, ПРОГЕСТЕРОНА И АНДРОГЕНОВ ПРИ НАСЛЕДСТВЕННЫХ И СПОРАДИЧЕСКИХ ОВАРИАЛЬНЫХ КАРЦИНОМАХ
by: А. L. Savаnevich, et al.
Published: (2022-01-01) -
Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01) -
ВЫЖИВАЕМОСТЬ БОЛЬНЫХ БИЛАТЕРАЛЬНЫМ ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ ПОСЛЕ НЕФРОНСОХРАНЯЮЩЕЙ ОПЕРАЦИИ. ОБЗОР ЛИТЕРАТУРЫ
Published: (2021-06-01) -
Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review
by: T. V. Gorodnova, et al.
Published: (2024-11-01) -
OVARIAN CANCER: INCIDENCE DYNAMICS IN NOVOKUZNETSK RESIDENTS FOR THE PERIOD 2008-2020
by: Светлана Владимировна Шрамко, et al.
Published: (2022-11-01)